Drug use in the United Kingdom is among the highest reported in Western Europe and people who inject drugs (PWID) experience stark health inequalities, with increased morbidity and early mortality. This report explores infections, as well as associated risks and behaviours, among people who inject drugs in the UK to the end of 2019. It also presents preliminary data on the impact of COVID-19 on PWID and services in 2020.
Summary report: Mitigating the impact of COVID-19 on HCV testing

Download
This is the written summary of a webinar held on 8th October on mitigating the impact of COVID-19 on HCV testing.
The first part of the webinar consisted of three presentations: Overview of testing, before and after COVID-19 - Helen Hampton, Lead Clinical Nurse for Blood Borne Virus, We Are With You; Outreach testing during the COVID-19 lockdown - Julian Surey, Find and Treat Team; and Postal testing or self-testing - Tracey Kemp, National Hepatitis C Strategy Lead, Change Grow Live
After a Q&A with the speakers, the audience went into breakout groups to discuss these types of testing in more detail. After this the leaders of each group fed back and summarised their group's discussion.